申请人:JANKOWSKI Orion D.
公开号:US20100035841A1
公开(公告)日:2010-02-11
Disclosed herein are compounds that inhibit the activity of particular tyrosine kinases. Methods for the preparation of such compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the compounds disclosed, alone or in combination with other therapeutic agents, for the treatment of tyrosine kinase-mediated diseases or conditions or tyrosine kinase-dependent diseases or conditions are provided.
本文公开了抑制特定酪氨酸激酶活性的化合物。公开了制备这些化合物的方法。还公开了包括这些化合物的药物组合物。提供了使用所述化合物单独或与其他治疗剂联合治疗酪氨酸激酶介导的疾病或病症或酪氨酸激酶依赖性疾病或病症的方法。